Skip to main content
SLQT logo

SLQT · SelectQuote, Inc.

Track SLQT — free
$5.01 -0.34 (-6.36%) At close · Nov 20
Market Cap
$44.95M
Shares
8.97M
Volume · Nov 20 97.65K Avg daily vol (4 sessions) 152.75K

Price & Indicators

 

Key stats

Close
$5.01
Fri 20 Nov
Open
$5.28
Fri 20 Nov
Average volume, 30 days
93K
shares a session
Short interest
104K
1.2% of shares · 1.4 days to cover
Day range
$4.85$5.28
Open $5.28 Close $5.01
52-week closing range
$5.01$34.40
Close $5.01 85.4% under the high
Short volume, last session
59%
Last earnings
Nov 4, 2026
Latest filing
10-Q · Nov 4
Price history
May 2020 to Nov 2026

Up next

Feb 4, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 16
Current report 8-K Events of Nov 10
Reverse Split of 1-for-20 Targets NYSE Listing Compliance

SelectQuote will effect a 1-for-20 reverse stock split effective 11:59 p.m. Eastern Time on November 16, 2026, with split-adjusted trading starting November 17, 2026, to regain NYSE compliance.

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Regulation FD disclosure
4 source passages
The Amendment will become effective at 11:59 p.m. Eastern Time on November 16, 2026 (the “Effective Time”). The Company’s common stock is expected to begin trading on a split-adjusted basis on the New York Stock Exchange (the “NYSE”) at market open on November 17, 2026. On November 13, 2026, the Company filed a Certificate of Amendment (the “Amendment”) to the Certificate of Incorporation with the Delaware Secretary of State to effect a one-for-twenty (1-for-20) reverse stock split (the “Reverse Stock Split”) of the Company’s outstanding common stock The Reverse Stock Split is intended to increase the per-share trading price of the Company’s common stock to regain compliance with the NYSE’s continued listing standards. Open the document at this passage
Nov 4
Earnings call
Adjusted EBITDA loss improves by more than $15 million

SelectQuote posted Fiscal 1Q revenue of $280 million, down 15%, and an adjusted EBITDA loss of $17 million, more than $15 million better year over year. Operating cash flow guidance remained at least $60 million for fiscal 2027.

4 source passages
Specifically, our adjusted EBITDA loss of $17 million represents more than $15 million of year-over-year improvement. As a result, consolidated revenue for Fiscal 1Q totaled $280 million, or 15% lower than a year ago. On the heels of the strong execution, we're pleased to reiterate our consolidated target of at least $60 million of operating cash flow in fiscal 2027. SelectQuote is poised for growth when carrier and consumer demand supports it. Open the document at this passage
Nov 4
Quarterly report 10-Q FY2027 Q1, ended Sep 30
Revenue Falls 15% as Net Loss Narrows

SelectQuote, Inc. reported that revenue declined 15% for the three months ended September 30, 2026, while net loss narrowed.

Revenue $280.01M ▼ 14.8% Net loss $20.3M Diluted EPS -$0.21
Read from the MD&A section
4 source passages
SelectQuote, Inc. (together with its subsidiaries, “SelectQuote”, the “Company”, “we”, “us”) Three Months Ended September 30, | | 2026 | 2025 | 2026 vs. 2025 Total revenue | 280,007 | 328,811 | (15)% Net loss | (20,301) | (30,459) Open the document at this passage
Nov 4
Current report 8-K
Fiscal 2027 guidance reiterated as quarterly revenue declines

SelectQuote reported fiscal 2027 first-quarter revenue of $280.0 million versus $328.8 million and Adjusted EBITDA of $(17.0) million versus $(32.1) million. Fiscal 2027 guidance calls for revenue of $1.35 billion to $1.45 billion and Adjusted EBITDA of $90 million to $115 million.

Financial results
3 source passages
SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the first quarter of fiscal year 2027 of $280.0 million compared to consolidated revenue for the first quarter of fiscal year 2026 of $328.8 million. Consolidated Adjusted EBITDA* for the first quarter of fiscal year 2027 was $(17.0) million compared to consolidated Adjusted EBITDA* for the first quarter of fiscal year 2026 of $(32.1) million. •Revenue expected in the range of $1.35 billion to $1.45 billion •Adjusted EBITDA* expected in the range of $90 million to $115 million •Operating Cash Flow expected to be more than $60 million Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.57B
Trailing 12 months
Net income (TTM)
$72.35M
Trailing 12 months
Revenue growth YoY
-14.8%
Year over year
Operating margin
5.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
72.2%
TTM · current market cap
Return on invested capital
10.3%
Trailing 12 months
Net cash
−$376.10M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.2%
Latest settlement · 1.4 days to cover
View all 125 metrics

AI Brief

Q4 FY26 earnings call · Aug 25, 2026
Q4 FY26

TL;DR. SelectQuote improved fiscal 2026 operating cash flow by $44 million, expects fiscal 2027 operating cash flow to approximately double to over $60 million, and targets over $30 million of annual savings while forecasting margin expansion. Fiscal 2026 adjusted EBITDA declined, fiscal 2027 revenue and adjusted EBITDA are guided lower, and the fourth quarter produced lower revenue, a net loss, and operating cash use.

Bullish
  • + Technology-enabled efficiencies are expected to produce over $30 million of annual expense savings for fiscal 2027.
  • + Fiscal 2027 guidance anticipates approximately 60 basis points of consolidated adjusted EBITDA margin expansion despite lower year-over-year adjusted EBITDA.
  • + Healthcare Services exited fiscal 2026 at an annual adjusted EBITDA run rate of nearly $50 million.
  • + Healthcare Services revenue increased 14% to $844.935 million in fiscal 2026.
Bearish
  • − Healthcare Services membership is expected to moderate in the first quarter of fiscal 2027 before finishing the year around fiscal 2026 levels.
  • − The Life segment faces a competitive term market and customer-acquisition costs that require monitoring.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −64%
below
Price vs 50-day avg −36%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −18%
trailing
6-month return −76%
trailing
YTD return −82%
this year
Relative strength −67%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $8 › 200d $14 — 200d above 50d
Institutional flow Distributing
-22% holders QoQ · +7 funds added
Insider flow Accumulating
Net +$446.3K over 90 days · 0% sells
Short interest Rising
1.16% of shares out · ▲ +40.2% MoM · 1.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
122 holders — near 3-yr low, contrarian setup
Squeeze score 57
elevated · 0–100
Fundamentals
Weak
Revenue growth +6%
Y/Y
EPS growth −700%
Y/Y
Free cash flow $27.6M
Balance sheet $354.1M
net debt
Quant / Vol
risk profile
Very High
Volatility 113%
annualized · 1-yr
Max drawdown −85%
past year
ATR 24.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 5
Latest guidance · from the Earnings Call filed Nov 4, 2026
Operating cash flow · fiscal 2027 at least $60M
Previous outlook earlier release · from the Earnings Call filed Aug 25, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA · 2027 $90M – $115M
Operating cash flow · 2027 at least $60M
Prior guidance period ended · from the 8-K filed May 5, 2026
Revenue · fiscal 2026 $1.61B – $1.71B
Guided vs delivered · last 5 settled
Revenue fiscal 2026
guided $1.61B – $1.71B
$1.62B In line
Revenue Fiscal Year 2024
guided $1.25B – $1.3B
$1.32B Beat +3.7%
Revenue Fiscal Year 2023
guided $950M – $970M
$1B Beat +4.5%
Revenue Full-Year Fiscal 2022
guided $810M – $850M
$764.05M Miss −7.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−64% Bearish
Price vs 50-day avg
−36% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $8 › 200d $14 — 200d above 50d
Institutional flow Distributing
-22% holders QoQ · +7 funds added
Insider flow Accumulating
Net +$446.3K over 90 days · 0% sells
Short interest Rising
1.16% of shares out · ▲ +40.2% MoM · 1.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
122 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $5 Now $5 · 0% Range high $34
vs 200-day avg -64% vs 50-day avg -36%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA Margin per MA/MS policy non-GAAP 13% twelve months ended September 30, 2026 —
Lifetime value of commissions per approved policy - Medicare Advantage $890 the three months ended September 30, 2026 —
Profitability per SelectRx member $107.6 the three months ended September 30, 2026 —
SelectRx members 99,753 as of September 30, 2026 —
Total premiums 38.51M the three months ended September 30, 2026 —
Trailing-twelve-month Adjusted EBITDA non-GAAP $157M Trailing-twelve-month —
Adjusted EBITDA non-GAAP $109.1M fiscal year 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income (loss) $62.19M
+$14.86M Share-based compensation expense
+$2.11M Transaction costs
+$17.49M Depreciation and amortization
+$0K Loss on disposal of property, equipment, and software, net
+$1M Impairment of equity-method investment
+$0K Impairment of long-lived asset
+$8.66M Loss on extinguishment of debt
-$55.8M Change in fair value of warrants
+$44.53M Interest expense, net
+$14.1M Income tax expense
= Adjusted EBITDA $109.13M
Approved policies - All other 71,298 Year Ended June 30, 2026 —
Healthcare Services Adjusted EBITDA Margin non-GAAP 3% Year Ended June 30, 2026 —
Submitted policies - All other 90,253 Year Ended June 30, 2026 —
Total Life Premiums $185.16M Year Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance Brokers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SLQT
SelectQuote, Inc.
this stock
$44.95M — +6.0% — 1.2%
MRSH
Marsh & Mclennan Companies, Inc.
$98.06B +11.2% +10.3% 24.7 1.3%
AJG
Arthur J. Gallagher & Co.
$71.60B +7.9% +10.1% 42.7 3.0%
AON
Aon plc
$70.66B -5.6% +7.7% 18.2 1.8%
WTW
Willis Towers Watson PLC
$30.52B +0.7% -2.2% 20.3 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
122
% held
32.9%
Net QoQ
-263.6K sh
Top holder
ABRAMS BISON INVESTMENTS,…
Held Float
View
Held by Funds
Fund positions
46
View
Short & Settlement
Short Interest Rising
Shares short
104.2K
Days to cover
1.4d
Change
+29.8K sh
View
Short Volume
Short vol %
59%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$0
As of
Oct 23, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$446.3K
Buyers / Sellers
5 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.6B
Net income (FY)
$62.2M
EPS diluted
$-1.20
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 16, 2026
This year
14

SelectQuote will effect a 1-for-20 reverse stock split effective 11:59 p.m. Eastern Time on November 16, 2026, with split-adjusted trading starting November 17, 2026, to regain NYSE compliance.

View
Proposed Sales
Value
$4.2K
Shares
4.0K
Filed
May 19, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
SelectQuote, Inc. Announces 1-for…
Published
Nov 13, 2026
View

Performance

5D 20D 120D MTD YTD
SLQT -43.3% -18.4% -75.7% -29.8% -82.2%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY -34.8% -9.2% -66.5% -21.1% -83.4%
Key facts CIK 1794783 CUSIP 816307300 13F (30d) 127 filings 112 filers Visit website Investor relations